In this issue:

• New Video: One Example of Dakota Doing the SP500 E-Mini

• Dakota Sale:  15% Reduction on Dakota End-of-Day... Grab it before Friday!

• Customer Comments

Video: Dakota End-of-Day Doing the SP500 E-Mini (ES)
Here we see the end-of-day Dakota doing the SP500 E-Mini (ES) using a simple bot we quickly put together for the August 2006 "Traders' Tips" in Stocks and Commodities magazine.  While we have better systems (more equity, smoother returns), such as the Double Smoothed Stochastics, this bot provides yet another insight into where the ES is going using some of Ehler's algorithms.

http://www.biocompsystems.com/products/Dakota/videos/ES/ES.htm

Questions or comments?  Email me at cmcook@biocompsystems.com

Back to top

Dakota Sale: 15% Reduction on Dakota End-of-Day
It is Dakota's first official sale, so join us now in a great value while it lasts... until Friday, June 16th, 2006.  Get Dakota or Dakota Express at a 15% reduction or upgrade from Express to the full standard edition.  And remember, you may automatically receive an additional Silver (10%), Gold (15%) or Platinum (25%) Preferred Customer Discount too!  We honor and respect our customers and the value we've shared together over the years.

Dakota's unique "anti-brittle" technologies provide you another excellent trading tool for your toolbox.  Easy to use, effective, truth telling, with walk-forward adaptive paper-traded results.  Avoid back optimized curve fitted brittle trading system like too many other tools.  Dakota is clearly different.

Waiting for Dakota R/T for intraday trading?   Here is your chance to get involved with Dakota now, learn it, then we'll apply 100% of your purchase price to Dakota R/T when it is released.

Step up to Dakota's First and Only Reduction...  Order Here:
http://www.biocompsystems.com/store/financial/index.htm

Upgrading Your Dakota?  Send an Email Request!
sales@biocompsystems.com
or phone it in at 1-952-746-5761

Thank you for supporting our on-going investment into Dakota and Dakota R/T.

Back to top

Customer Comments
We always like to share the comments receive.  I, of course, particularly like this one [wink]...

• June 11th:  C.L. Says: "... where else would you find a trading technology company where its President (that would be Carl!) would volunteer hours on a Saturday to help work through some product issues...   You don't find this kind of support in many places."

The "product issue" I was helping C.L. with was integrating into Dakota the bots he's creating using Visual Studio 2005.  Coming soon!

Thanks C.L. !

Closure
If you find this newsletter interesting, please stay subscribed.  If you think others might like getting it, forward this email to them or post a link to our website in your favorite trading discussion group.  That helps us grow.  We'd appreciate it.  If you have suggestions, please email me at cmcook@biocompsystems.com.

These documents are provided for informational purposes only. The information contained in this document represents the current view of BioComp Systems on the material discussed as of the date of publication.  Materials written should not be interpreted to be a commitment on the part of BioComp and BioComp cannot guarantee the accuracy of any information presented after the date of publication.   INFORMATION PROVIDED IN THIS DOCUMENT IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND FREEDOM FROM INFRINGEMENT. Statements of equity performance are hypothetical and have not been substantiated by records of actual trading.  Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading.  Also, since the trades have not actually been executed, the results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity.  Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to those mentioned.

The user assumes the entire risk as to the accuracy and the use of this document. This document may be copied and distributed subject to the following conditions: 1) The entire document must be copied without modification; 2) All copies must contain BioComp's copyright notice and any other notices provided therein; and 3) This document may not be distributed for profit.  All trademarks acknowledged.  (C) Copyright BioComp Systems, Inc. 2006.